Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 27, 2021 16:05 ET | Source: ORPHAZYME A/S

Orphazyme to present at upcoming investor conferences

Orphazyme A/SInvestor news No. 05/2021Company Registration No. 32266355 Copenhagen, Denmark and Chicago, IL, USA, April 27, 2021 – Orphazyme A/S [ORPHA.CO (DK); ORPH (US)], a late-stage...
April 22, 2021 00:34 ET | Source: ORPHAZYME A/S

New long-term share-based incentive program

Orphazyme A/SCompany announcement No. 13/2021Company Registration No. 32266355 Copenhagen, Denmark, April 22, 2021 – Orphazyme A/S [ORPHA.CO (DK); ORPH (US)], a late-stage biopharmaceutical...
March 29, 2021 01:00 ET | Source: ORPHAZYME A/S

Orphazyme announces topline results from pivotal trial of arimoclomol for Inclusion Body Myositis (IBM)

Orphazyme A/SCompany announcement No. 12/2021Inside informationCompany Registration No. 32266355 Copenhagen –...
March 25, 2021 15:48 ET | Source: ORPHAZYME A/S

Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities

Orphazyme A/SCompany announcement No....
March 25, 2021 15:37 ET | Source: ORPHAZYME A/S

Articles of Association for Orphazyme A/S

Orphazyme A/SCompany announcement No. 10/2021 ...
March 25, 2021 15:20 ET | Source: ORPHAZYME A/S

Capital increase of 3,854 shares in Orphazyme A/S as a result of the exercise of Restricted Share Units

Orphazyme A/SCompany announcement No....
March 25, 2021 13:53 ET | Source: ORPHAZYME A/S

Resolutions passed at the Annual General Meeting

Orphazyme A/SCompany announcement No....
March 03, 2021 13:06 ET | Source: ORPHAZYME A/S

Correction: Notice to convene Annual General Meeting

Orphazyme A/SCompany announcement No. 07/2021 ...
March 03, 2021 10:00 ET | Source: ORPHAZYME A/S

Notice to convene Annual General Meeting

Orphazyme A/SCompany announcement No. 07/2021 ...
March 02, 2021 01:00 ET | Source: ORPHAZYME A/S

Orphazyme reports business highlights and financial results in Annual Report 2020

Orphazyme A/SCompany announcementNo. 06/2021Company Registration No. 32266355 -Advanced arimoclomol in 4 rare disease indications; announced global brand name of arimoclomol (MIPLYFFATM1);...